NEW YORK--(BUSINESS WIRE)--Izun Pharmaceuticals Corporation (“Izun”, izunpharma.com), a clinical stage company focused on developing high efficacy products based on pharmaceutical compounds derived from botanical sources announced today that Jack Talley, Chief Executive Officer will present at the 18th Annual BIO CEO & INVESTOR conference taking place on February 8-9, 2016 at the Waldorf Astoria Hotel in New York City. Mr. Talley’s presentation will take place on Tuesday, February 9 at 9:30 AM EST in the Park North room in the multiple therapeutics track of the conference.
